Resources

Our latest news, blogs, reports, publications and upcoming events






























News, blogs, events, reports and more

Read our latest press releases, hear our most recent media appearances, and see which upcoming events we are attending.

Subscribe to our social channels to ensure you get our updates, news and announcements as and when they happen.




Share
LinkedIn X Link



Blogs
07 October 2020
Understanding PK/PD using pre-clinical models

Lessons for efficacy studies at AxisBio





Blogs
07 October 2020
Principles and modelling of pharmacokinetic and pharmacodynamic relationships

How PK-PD modelling can be applied in early stage drug discovery


News
06 October 2020
Oncimmune and Medicines Discovery Catapult awarded UK Government funding for development of an Infectious Disease research tool for use in COVID-19

Validated research tool to be used to predict disease severity and individual therapeutic response to COVID-19 in aid of rapid vaccine and drug development.


Blogs
30 September 2020
Designing formulations for preclinical and early stage clinical studies

How the formulation of a compound can be optimised to maximise dose and absorption in preclinical studies


Blogs
30 September 2020
IKKɛ/TBK1

A case study of approaches to turning fragment hits into drug candidates


Blogs
30 September 2020
Synthetic chemistry aspects of drug discovery and early development projects

The different skills required from early drug discovery to development phases


Blogs
23 September 2020
In-silico drug design

What to do, what not to do


Blogs
23 September 2020
Optimising ADME and PK properties

Common mistakes made and how to identify and resolve the key issues


Blogs
23 September 2020
In vivo imaging to understand the biodistribution of a candidate compound

How imaging technologies can be used to establish the biodistribution and accumulation of the compounds in vivo






Partner with us and make sure your next move counts

See how we can help support you with your next drug discovery project.

Speak to us